[PMC free article] [PubMed] [CrossRef] [Google Scholar] 13. attached layer surrounding the cell wall (7). Predominantly consisting of polysaccharides, the capsule is usually shed by under culture conditions that include detergents, which is the case in most studies (6). grown without detergent has been described to have a distinct phenotype, exhibiting pronounced characteristics regarding the MICs of antibiotics (8), drug tolerance (9), and gene expression (10). We show here that cultivation of in detergent-free broth causes retention of EsxA around the bacterial surface, resulting in a phenotype of that rapidly induces macrophage cell death. Similarly, lung surfactant, which has detergent-like properties, removes EsxA from the bacterial surface, suggesting a novel role for lung surfactant in antimycobacterial defense. RESULTS bacteria cultivated without detergent retain EsxA on their surface. Omitting detergent from the broth to preserve the capsule-like layer (6), we observed that EsxA accumulated at the bacterial surface after 3 to 6?days of incubation (Fig. 1A and ?andB).B). EsxA could not be detected when detergent was used in the broth, on EsxA-deficient cultivated without detergent, or in the control staining without primary antibody (Fig. 1A). The effect was more pronounced on bacterial aggregates consisting of two or more bacteria (the prevailing morphological structure in detergent-free cultures) (Fig. 1B). Immunogold labeling of EsxA followed by transmission electron microscopy (TEM) confirmed the presence of EsxA around the bacterial surface, while it was absent from the EsxA-deficient mutant and Tween 80 broth-cultivated wild-type bacteria (Fig. 1C and ?andDD). Open in a separate window FIG 1 EsxA can be detected on the surface of after cultivation in the absence of detergent or surfactant. (A and B) H37Rv wild type (left) or the EsxA-deleted strain H37Rv (right) was cultivated with or without Tween 80 and for the indicated times. Fixed bacteria were stained with anti-EsxA antibody and an Alexa Fluor 594-conjugated secondary antibody. The images in panel A are from bacteria cultivated for 6?days. In the samples for the antibody control images (fourth column), the anti-EsxA antibody was omitted. Images were obtained using a 100 (numerical aperture, 1.45) objective. Bars, 5?m. (B) EsxA-positive single bacteria or aggregates (2 bacteria) were expressed as a percentage of all single bacteria or aggregates. Day 0 indicates the initial stock culture which contained 0.05% Tween 80. Bars and error bars depict means and SEMs from three impartial experiments (on average, 79 bacteria or aggregates were analyzed per sample; range, 17 to 441). Significant differences between the time points were tested with 2-way analysis of variance comparing all time points to the day 0 time point using the Bonferroni test for multiple comparisons, and the earliest significant time point for each group is usually indicated by asterisks. (C and D) H37Rv or H37Rv was fixed after 6?days of cultivation with or without Tween 80, followed by immunogold labeling for EsxA and TEM analysis. (C) Representative images are shown. Arrows, EsxA-positive debris; arrowheads, immunogold particles in the bacterial cell wall. The unfavorable control (neg ctrl) was the wild type (wt) grown without detergent, where the EsxA antibody was omitted during the labeling procedure. (D) The amount of immunogold particles per bacterium was quantified from the TEM pictures in a TK05 blind fashion. Bars and Thy1 error bars show means and SEMs for 30 to 54 bacteria per sample. Significant differences were TK05 tested with a 1-way analysis of variance, followed by Tukeys test comparing all groups. (E) The H37Rv wild type was cultured in broth made up of TK05 0.05% Tween 80 or without detergents and increasing amounts of the bovine lung surfactant Curosurf. Bacteria were fixed, stained, imaged, and analyzed as described in the legend to panels A and B. Bars and error bars show means and SEMs from 5 experiments (on average, 106 bacteria were analyzed per.
Categories
- 34
- 5- Receptors
- A2A Receptors
- ACE
- Acetylcholinesterase
- Adenosine Deaminase
- Adenylyl Cyclase
- Adrenergic ??2 Receptors
- Alpha2 Adrenergic Receptors
- Annexin
- Antibiotics
- ATPase
- AXOR12 Receptor
- Ca2+ Ionophore
- Cannabinoid
- Cannabinoid (GPR55) Receptors
- CB2 Receptors
- CCK Receptors
- Cell Metabolism
- Cell Signaling
- Cholecystokinin2 Receptors
- CK1
- Corticotropin-Releasing Factor1 Receptors
- DHCR
- DMTases
- DNA Ligases
- DNA Methyltransferases
- Dopamine D1 Receptors
- Dopamine D3 Receptors
- Dopamine D4 Receptors
- Endothelin Receptors
- EP1-4 Receptors
- Epigenetics
- Exocytosis & Endocytosis
- Fatty Acid Synthase
- Flt Receptors
- GABAB Receptors
- GIP Receptor
- Glutamate (Kainate) Receptors
- Glutamate (Metabotropic) Group III Receptors
- Glutamate (NMDA) Receptors
- Glutamate Carboxypeptidase II
- Glycogen Phosphorylase
- Glycosyltransferase
- GnRH Receptors
- Heat Shock Protein 90
- hERG Channels
- Hormone-sensitive Lipase
- IKK
- Imidazoline Receptors
- IMPase
- Inositol Phosphatases
- Kisspeptin Receptor
- LTA4 Hydrolase
- M1 Receptors
- Matrixins
- Melastatin Receptors
- mGlu Group III Receptors
- mGlu5 Receptors
- Monoamine Oxidase
- Motilin Receptor
- My Blog
- Neutrophil Elastase
- Nicotinic (??4??2) Receptors
- NKCC Cotransporter
- NMU Receptors
- Nociceptin Receptors
- Non-Selective
- Non-selective 5-HT
- OP3 Receptors
- Opioid, ??-
- Orexin2 Receptors
- Other
- Other Oxygenases/Oxidases
- Other Transcription Factors
- p38 MAPK
- p53
- p56lck
- PAF Receptors
- PDPK1
- PKC
- PLA
- PPAR
- PPAR??
- Proteasome
- PTH Receptors
- Ras
- RNA Polymerase
- Serotonin (5-HT2B) Receptors
- Serotonin Transporters
- Sigma2 Receptors
- Sodium Channels
- Steroid Hormone Receptors
- Tachykinin NK1 Receptors
- Tachykinin NK2 Receptors
- Tachykinin, Non-Selective
- Telomerase
- Thyrotropin-Releasing Hormone Receptors
- Topoisomerase
- trpp
- Uncategorized
- USP
Recent Posts
- 2012) using the Phenotypic Characteristic Search for human strains with markers for resistance to Adamantane, Oseltamivir, or both drugs
- Tissue were homogenized into single-cell suspensions and put through red bloodstream cell lysis
- A phase I/II study investigated the safety and efficacy of concurrent local palliative RT and durvalumab (PD-L1 inhibitor) in 10 patients with unresectable or metastatic advanced solid tumors [136]
- We believe that this hypothesis-generating study could open new avenues for exploring oxidative stress as a potential pathogenetic and, hypothetically, therapeutic target for mitigating CLL strong class=”kwd-title” Keywords: Leukemia, Lymphocytic, Gilbert’s, Syndrome Gilbert’s syndrome (GS) is the most common inherited disorder of bilirubin glucuronidation
- Such costs aren’t simple for tertiary-care hospitals in growing countries sometimes, since these already are powered by minimal budget which switches into provision of fundamental medical services mostly, laboratory, radiology, pharmacy services, and bed space
Tags
a 67 kDa type I transmembrane glycoprotein present on myeloid progenitors
and differentiation. The protein kinase family is one of the largest families of proteins in eukaryotes
Apoptosis
bladder
brain
breast
cell cycle progression
cervix
CSP-B
Cyproterone acetate
EGFR) is the prototype member of the type 1 receptor tyrosine kinases. EGFR overexpression in tumors indicates poor prognosis and is observed in tumors of the head and neck
EM9
endometrium
erythrocytes
F3
Goat polyclonal to IgG H+L)
Goat polyclonal to IgG H+L)Biotin)
GRK4
GSK1904529A
Igf1
Mapkap1
monocytes andgranulocytes. CD33 is absent on lymphocytes
Mouse monoclonal to CD33.CT65 reacts with CD33 andtigen
Palomid 529
platelets
PTK) or serine/threonine
Rabbit Polyclonal to ARNT.
Rabbit polyclonal to BMPR2
Rabbit Polyclonal to CCBP2.
Rabbit Polyclonal to EDG4
Rabbit polyclonal to EIF4E.
Rabbit polyclonal to IL11RA
Rabbit polyclonal to LRRIQ3
Rabbit Polyclonal to MCM3 phospho-Thr722)
Rabbit Polyclonal to RBM34
SB 216763
SKI-606
SNX-5422
STK) kinase catalytic domains. Epidermal Growth factor receptor
stomach
stomach and in squamous cell carcinoma.
TNFSF8
TSHR
VEGFA
vulva